Difference between revisions of "Part:BBa K5302002:Design"

 
(→‎References)
 
Line 18: Line 18:
  
 
===References===
 
===References===
 +
[1]Zhu S, Fan S, Tang T, Huang J, Zhou H, Huang C, Chen Y, Qian F. Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration. Bioeng Transl Med. 2023 May 4;8(6):e10523. doi: 10.1002/btm2.10523. PMID: 38023710; PMCID: PMC10658565.

Latest revision as of 04:27, 1 October 2024


8IJZ


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Please be advised that all listed genes have undergone codon optimization for our chassis strain, Escherichia coli Nissle 1917 (EcN). For those considering alternative chassis organisms, it is recommended to reassess the necessity of codon optimization.



Source

Source Organism: Homo sapiens

References

[1]Zhu S, Fan S, Tang T, Huang J, Zhou H, Huang C, Chen Y, Qian F. Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration. Bioeng Transl Med. 2023 May 4;8(6):e10523. doi: 10.1002/btm2.10523. PMID: 38023710; PMCID: PMC10658565.